Truist lowered the firm’s price target on Varonis (VRNS) to $50 from $70 and keeps a Buy rating on the shares after its Q3 results. The stock fell after weaker than guided Q3 top line results due to deterioration in renewal rates across its On-Prem segment which it has been migrating customers from the past three years, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS: